Beta-Carotene (natural) — Hermetica Encyclopedia
Compound · Mineral

Beta-Carotene (natural)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Beta-carotene is a provitamin A carotenoid that undergoes enzymatic cleavage by intestinal 15,15'-dioxygenase to form two molecules of retinal, which is subsequently reduced to retinol (vitamin A), with the body self-regulating this conversion downward when vitamin A status is already sufficient. Dietary beta-carotene from food sources provides safe provitamin A activity—6 mg of dietary beta-carotene yields approximately 1 mg of retinol activity equivalent (RAE)—and epidemiological evidence consistently associates higher dietary intake with reduced risk of ophthalmic, metabolic, and cardiovascular diseases, an association not replicated by high-dose supplementation.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryCompound
GroupMineral
Evidence LevelPreliminary
Primary Keywordbeta-carotene benefits
Beta-Carotene, Natural close-up macro showing natural texture and detail — rich in rar-beta, proliferation, lutein
Beta-Carotene (natural) — botanical close-up

Health Benefits

**Provitamin A Activity and Vision Support**
Beta-carotene converts to retinol, the aldehyde form of which (retinal) is an essential chromophore in rhodopsin within rod photoreceptor cells; adequate vitamin A status from dietary carotenoids supports night vision, corneal integrity, and prevention of xerophthalmia.
**Antioxidant and Cellular Protection**
As a lipophilic carotenoid, beta-carotene quenches singlet oxygen and scavenges peroxyl radicals within cellular membranes and low-density lipoproteins, reducing oxidative modification of lipids and protecting DNA from strand breaks induced by reactive oxygen species.
**Immune System Modulation**
Retinol derived from beta-carotene supports epithelial barrier integrity, differentiation of T-helper cells, and production of secretory IgA, while beta-carotene itself upregulates natural killer cell activity and cytokine signaling, enhancing innate immune defense.
**Photoprotection in Photosensitivity Disorders**
High-dose beta-carotene (30–300 mg/day in adults) has demonstrated clinical utility in erythropoietic protoporphyria by quenching porphyrin-generated singlet oxygen in the skin, reducing photosensitivity reactions; evidence for polymorphous light eruption is similarly supported at 75–180 mg/day.
**Cardiovascular Disease Risk Reduction (Dietary)**
Observational and cohort data associate higher dietary beta-carotene intake with lower rates of atherosclerosis, partly through inhibition of LDL oxidation and modulation of inflammatory biomarkers such as C-reactive protein and interleukin-6, though supplemental forms have not replicated this benefit in randomized trials.
**Metabolic and Glycemic Health**
Plasma carotenoid levels, including beta-carotene, are inversely correlated with markers of insulin resistance and type 2 diabetes risk in epidemiological studies, potentially through reduction of oxidative stress in pancreatic beta cells and modulation of adipokine signaling in adipose tissue.
**Skin Health and Photoaging Mitigation**
Dietary beta-carotene accumulates in skin tissue, where its antioxidant activity attenuates UV-induced lipid peroxidation and matrix metalloproteinase activation, providing mild but measurable photoprotection against erythema and contributing to carotenoid-associated skin pigmentation associated with perceived health.

Origin & History

Beta-Carotene, Natural growing in Australia — natural habitat
Natural habitat

Beta-carotene is a naturally occurring carotenoid pigment biosynthesized by plants, algae, and some fungi across virtually every inhabited continent, with the highest concentrations found in orange, yellow, and dark-green vegetables such as carrots (originating in Central Asia), sweet potatoes (native to Central and South America), and spinach (originating in ancient Persia). The microalgae Dunaliella salina, cultivated commercially in hypersaline open ponds—optimally at 24% NaCl salinity—represents the primary biotechnological source, yielding 30–40 g of beta-carotene per square meter per day of dry biomass under controlled conditions in regions like Australia, Israel, and China. Traditional dietary exposure has been continuous throughout human agricultural history wherever colorful plant foods were cultivated and consumed.

Beta-carotene itself was not isolated as a distinct compound until 1831, when Heinrich Wilhelm Ferdinand Wackenroder crystallized it from carrot roots and named it from the Latin 'carota'; however, the foods richest in beta-carotene—carrots, sweet potatoes, and leafy greens—have been cultivated and valued for thousands of years across Persian, Chinese, Mesoamerican, and Mediterranean cultures, often specifically for their association with eye health and vitality. Ancient Ayurvedic texts referenced the therapeutic use of carrot preparations (gajar) for vision preservation and digestive health, while Egyptian and Greek physicians recommended liver (rich in preformed vitamin A, the endpoint of beta-carotene conversion) for night blindness as early as 1500 BCE. The carotenoid's orange-yellow pigment held cultural symbolism in Mesoamerican culinary traditions where maize varieties and squashes colored with carotenoids were dietary staples and ritual offerings. Modern biotechnological cultivation of Dunaliella salina in Israel and Australia beginning in the 1980s marked the transition from chemical synthesis to natural extraction, driven by consumer preference for plant-derived supplement ingredients and recognition that the natural mixed-isomer profile may confer different biological activity than synthetic all-trans beta-carotene.Traditional Medicine

Scientific Research

The clinical evidence base for beta-carotene is substantial but heavily nuanced: while large-scale randomized controlled trials (RCTs) including the ATBC trial (n=29,133 male smokers) and CARET trial (n=18,314 high-risk individuals) definitively demonstrated that high-dose supplemental beta-carotene (20–30 mg/day) significantly increased lung cancer incidence and all-cause mortality in smokers and asbestos-exposed workers, these findings do not translate to dietary beta-carotene from food sources, which consistently shows inverse associations with chronic disease in prospective cohort studies. For erythropoietic protoporphyria, clinical case series and small controlled studies support therapeutic doses of 30–300 mg/day with meaningful reductions in photosensitivity, representing one of the stronger intervention-specific evidence bodies. Evidence for prevention of cataracts, heart disease, and cognitive decline via supplementation is consistently null or negative in RCT settings, leading health authorities to explicitly discourage supplemental beta-carotene in smokers and high-risk populations. The overall evidence picture supports dietary beta-carotene as beneficial and safe, supplemental beta-carotene as risk-stratified and context-dependent, with evidence quality rated moderate-to-strong for safety differentiation but limited for specific therapeutic disease prevention claims.

Preparation & Dosage

Beta-Carotene, Natural ground into fine powder — pairs with Beta-carotene bioavailability and antioxidant efficacy are enhanced by co-consumption with dietary fats (particularly monounsaturated and polyunsaturated fatty acids such as olive oil or avocado), which are required for micellarization in the gut lumen and SR-BI-mediated enterocyte uptake—one study demonstrated a 4.5-fold increase in carotenoid absorption from salad when full-fat dressing replaced fat-free dressing.
Traditional preparation
**Dietary Food Sources (Preferred Form)**
100–200 g daily of cooked carrots (~8,279 mcg/100 g), sweet potatoes (~9,406 mcg/100 g), or cooked spinach (~6,103 mcg/100 g); cooking and chopping break down cell walls and increase carotenoid bioaccessibility by up to 3-fold compared to raw consumption
Consume .
**Oral Capsules/Softgels (Supplemental)**
6–15 mg/day (10,000–25,000 IU) for adults; 3–6 mg/day for children; take with a fat-containing meal to optimize micellarization and SR-BI-mediated absorption in enterocytes
Standard general supplementation .
**Therapeutic Dose — Erythropoietic Protoporphyria**
30–300 mg/day in divided doses; children 30–150 mg/day; titrate from lower end and monitor skin yellowing (carotenodermia) as a biomarker of tissue saturation; continue for 4–8 weeks before assessing sun tolerance response
Adults .
**Therapeutic Dose — Polymorphous Light Eruption**
75–180 mg/day; children 30–150 mg/day; taken orally in divided doses with meals during high-UV-exposure seasons
Adults .
**Natural Algal Extract (Dunaliella salina)**
Available as standardized algal oil or powder with mixed carotenoid profile (9-cis and all-trans beta-carotene isomers); enhanced bioaccessibility compared to crystalline synthetic forms; no established standardization percentage but preferred for supplement use over synthetic all-trans-only forms.
**Retinol Activity Equivalents Conversion**
2 mcg of supplemental beta-carotene = 1 mcg RAE; 12 mcg of food-matrix beta-carotene = 1 mcg RAE; these differ because food-matrix carotenoids have significantly lower bioavailability (~14–45%) than purified supplemental forms
**Contraindicated High-Dose Use**
20–30 mg/day as isolated supplements are contraindicated in current or former smokers and individuals with significant asbestos or occupational carcinogen exposure based on ATBC and CARET trial outcomes
Doses exceeding .

Nutritional Profile

Beta-carotene is a lipophilic tetraterpenoid (C₄₀H₅₆, molecular weight 536.87 g/mol) with no caloric contribution as an isolated compound. In whole food sources, the carotenoid matrix is accompanied by vitamin C (carrots ~5.9 mg/100 g), potassium (~235 mg/100 g in carrots), dietary fiber (~2.8 g/100 g in carrots), and alpha-carotene (~3,477 mcg/100 g in cooked carrots), which is also a provitamin A carotenoid. Bioavailability of food-matrix beta-carotene ranges from 14–45% depending on food preparation (heat, mechanical disruption, and oil co-consumption increase absorption), food matrix crystalline structure (reduces absorption), and co-ingestion of plant sterols (which competitively inhibit micellarization and reduce carotenoid uptake by ~25%). Tissue distribution after absorption follows: liver stores 8–12% of circulating beta-carotene, muscle tissue 2–3%, and adipose tissue contains 0.20–0.70 nmol/g, with plasma concentrations varying widely based on dietary patterns (typical range 0.3–0.6 µmol/L in Western adults, up to 2–3 µmol/L in high-vegetable-intake populations). No macronutrient content is contributed by beta-carotene as an isolated nutrient.

How It Works

Mechanism of Action

Beta-carotene is absorbed via passive diffusion in the proximal small intestine, incorporated into mixed micelles facilitated by dietary fat, and taken up by enterocytes through scavenger receptor class B type I (SR-BI) and CD36 transporters. Within enterocytes, the enzyme beta-carotene 15,15'-monooxygenase 1 (BCMO1, also called BCO1) catalyzes the central cleavage of the C15=C15' double bond, producing two molecules of retinal (retinaldehyde), which are then reduced to retinol by retinal reductases and esterified for incorporation into chylomicrons for lymphatic transport. The body's self-regulatory mechanism operates primarily through BCMO1 expression downregulation when hepatic and systemic vitamin A (retinol) stores are replete, and through the actions of retinoic acid as a nuclear ligand for retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which govern transcription of genes controlling cell differentiation, proliferation, and immune response. In its unmodified form, beta-carotene acts as a chain-breaking antioxidant by donating electrons to neutralize singlet oxygen (¹O₂) and lipid peroxyl radicals (LOO•) within lipid bilayers and plasma lipoproteins, a mechanism that is concentration- and partial-pressure-dependent and may paradoxically shift toward pro-oxidant activity at high supplemental doses in high-oxygen environments such as lung tissue in smokers.

Clinical Evidence

The two most pivotal clinical trials—ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, n=29,133) and CARET (Beta-Carotene and Retinol Efficacy Trial, n=18,314)—were designed to test whether supplemental beta-carotene could prevent lung cancer in high-risk populations but were terminated early when interim analyses revealed 18% and 28% increases in lung cancer incidence, respectively, in the supplemented groups compared to placebo. These findings sharply contrast with observational data: the Nurses' Health Study and Health Professionals Follow-up Study cohorts consistently found that higher dietary carotenoid intake was associated with 20–40% lower relative risk of cardiovascular events and age-related macular degeneration. For erythropoietic protoporphyria, a systematic review of available case series and small trials found that 60–75% of patients reported clinically meaningful improvement in sun tolerance at doses of 60–180 mg/day, though the evidence base consists primarily of open-label studies. Clinical confidence is therefore high for the harm of high-dose supplementation in smokers, moderate for dietary protection against chronic disease, and low-to-moderate for most other therapeutic claims.

Safety & Interactions

Natural dietary beta-carotene from food sources is considered safe at all achievable dietary intake levels with no documented toxicity; unlike preformed vitamin A (retinol), excess dietary beta-carotene does not cause hypervitaminosis A because intestinal and hepatic conversion is self-limited by retinol status, and the primary sign of excess intake is reversible carotenodermia (harmless orange-yellow skin discoloration). High-dose supplemental beta-carotene (20–30 mg/day) is contraindicated in smokers and individuals with heavy alcohol use or asbestos exposure, based on statistically significant increases in lung cancer incidence (18–28% relative risk increase) and all-cause mortality observed in the ATBC and CARET RCTs; this risk is not observed with dietary sources. Drug interactions include: cholestyramine and colestipol (bile acid sequestrants) reduce carotenoid absorption; orlistat (lipase inhibitor) impairs fat-soluble carotenoid uptake; mineral oil functions similarly; plant sterols and stanols in functional foods reduce absorption by approximately 25%. The upper tolerable intake level for preformed vitamin A is 3,000 mcg RAE/day (which encompasses beta-carotene conversion contributions), and supplemental beta-carotene is generally not recommended during pregnancy beyond RDA-level provitamin A intake given the potential for variable conversion and the availability of safer food sources.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

β-CaroteneProvitamin AAll-trans-beta-caroteneCaroteneDunaliella carotenoidβ,β-CaroteneFood orange 5

Frequently Asked Questions

Is natural beta-carotene safer than synthetic beta-carotene supplements?
Yes, natural dietary beta-carotene from food sources is considered safe at all achievable intake levels because the body self-regulates its conversion to vitamin A via downregulation of the BCO1 enzyme when retinol stores are sufficient, preventing hypervitaminosis A. Synthetic high-dose supplemental beta-carotene (20–30 mg/day), by contrast, significantly increased lung cancer risk in smokers in both the ATBC trial (18% increase, n=29,133) and the CARET trial (28% increase, n=18,314), making it contraindicated in that population. Natural algal sources from Dunaliella salina also provide a mixed 9-cis and all-trans isomer profile that may behave differently biologically than the all-trans-only synthetic form.
How much beta-carotene do I need per day from food?
There is no standalone Recommended Dietary Allowance (RDA) for beta-carotene; instead, it contributes to the Vitamin A RDA expressed as Retinol Activity Equivalents (RAE): 900 mcg RAE/day for adult men and 700 mcg RAE/day for adult women. Because food-matrix beta-carotene has approximately 12:1 conversion efficiency (12 mcg beta-carotene = 1 mcg RAE), meeting the vitamin A RDA entirely from beta-carotene would require roughly 8,400–10,800 mcg of dietary beta-carotene daily—achievable with approximately 100–130 g of cooked sweet potato or carrots. Most nutrition authorities recommend obtaining beta-carotene from a varied diet of colorful fruits and vegetables rather than supplements, with typical Western dietary intake averaging 2–6 mg/day.
Can beta-carotene cause cancer in smokers?
High-dose supplemental beta-carotene has been shown to significantly increase lung cancer risk in smokers and individuals with heavy occupational carcinogen exposure. The ATBC trial found an 18% increase in lung cancer incidence among male smokers taking 20 mg/day of supplemental beta-carotene, while the CARET trial was terminated early after a 28% increase in lung cancer was observed at 30 mg/day in a mixed cohort of smokers and asbestos-exposed workers. This risk is mechanistically attributed to the pro-oxidant behavior of high-concentration beta-carotene in the high-oxygen, oxidatively stressed lung environment of smokers, and it does not apply to dietary beta-carotene from food sources.
What foods are highest in beta-carotene?
The richest dietary sources of beta-carotene include boiled sweet potato (~9,406 mcg per 100 g), cooked carrots (~8,279 mcg per 100 g), and cooked spinach (~6,103 mcg per 100 g), with other significant sources including butternut squash, kale, cantaloupe, and red bell peppers. Bioavailability from these foods is meaningfully enhanced by cooking (which disrupts carotenoid-protein complexes and plant cell walls), mechanical processing (chopping or pureeing), and co-consumption with dietary fat such as olive oil, which is required for micellarization in the small intestine. Vegans and vegetarians consuming high quantities of these foods typically achieve intakes of 9 mg/day or more compared to the average 2 mg/day in omnivorous Western populations.
Does beta-carotene help with sun sensitivity or skin conditions?
Beta-carotene has the clearest therapeutic evidence in erythropoietic protoporphyria (EPP), a rare inherited photosensitivity disorder where it functions by quenching porphyrin-generated singlet oxygen in skin tissue; clinical case series and small controlled studies report that 60–75% of EPP patients experience meaningful improvement in sun tolerance at doses of 30–300 mg/day in adults, with therapeutic response typically appearing after 4–8 weeks of treatment. For polymorphous light eruption (a more common sun sensitivity condition), doses of 75–180 mg/day in adults have shown benefit in small studies, though the evidence base is less robust. General photoprotection in healthy individuals—such as reducing UV-induced erythema—has been documented at dietary and supplemental intake levels, but the effect size is modest and cannot substitute for sunscreen or UV-protective clothing.
Does beta-carotene from Dunaliella salina absorb better with fat or oil?
Beta-carotene is a fat-soluble compound, so absorption is significantly enhanced when consumed with dietary fat or oil. Studies show that taking beta-carotene supplements with a meal containing fat (such as olive oil, nuts, or fatty fish) can increase bioavailability by 2–5 fold compared to taking it on an empty stomach. Dunaliella salina–derived beta-carotene, being in a lipophilic form, benefits particularly from this synergy with dietary lipids.
Is beta-carotene safe for pregnant or breastfeeding women?
Excessive preformed vitamin A (retinol) during pregnancy carries teratogenic risk, but beta-carotene from food and moderate supplemental doses is considered safe because conversion to retinol is regulated and down-regulated when vitamin A status is adequate. Most guidelines recommend pregnant women obtain beta-carotene primarily from dietary sources rather than high-dose supplements, and individual risk assessment with a healthcare provider is advised. Natural beta-carotene from Dunaliella salina at typical dietary supplement levels (5,000–10,000 IU) poses minimal risk compared to synthetic retinol supplements.
What is the clinical evidence that beta-carotene improves eye health and night vision?
Beta-carotene's conversion to retinal (the active form in rhodopsin) is well-established biochemically, and observational studies link higher dietary carotenoid intake to reduced age-related macular degeneration risk. However, large randomized controlled trials (including the AREDS study) show mixed results: while adequate vitamin A status prevents xerophthalmia and supports corneal health, supplemental beta-carotene alone did not significantly slow macular degeneration progression in high-risk populations. The strongest evidence supports beta-carotene's role in maintaining normal vision and preventing deficiency-related blindness rather than reversing existing age-related vision loss.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.